Camille Locht
36Patents
6h-index
44Co-inventors
69Inventor score
Filing activity: Mar 25, 1986 → Aug 3, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5786189A | Vaccine | Human Necessities | 59 | Expired |
| US6841358B1 | RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY BORDETELLA PERTUSSIS, METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OF VACCINATING ACTIVE PRINCIPLES | Chemistry; Metallurgy | 24 | Expired |
| US4883761A | Pertussis toxin gene: cloning and expression of protective antigen | Human Necessities | 22 | Expired |
| US6040427A | Vaccine | Human Necessities | 13 | Expired |
| US7833699B2 | Detection of tuberculosis and infection by Mycobacterium tuberculosis using HBHA | Physics | 10 | Active |
| US9528086B2 | Recombinant bordetella strains | Emerging Cross-Sectional Technologies | 6 | Active |
| US9655959B2 | Adenylate cyclase deficient bordetella strains | Human Necessities | 6 | Active |
| US6660261B1 | Bordetella strain expressing the FHA hybrid, liposomes and vaccines | Emerging Cross-Sectional Technologies | 5 | Expired |
| US9415077B2 | Effect of an attenuated Bordetella strain against allergic disease | Human Necessities | 5 | Active |
| US9119804B2 | Live attenuated bordetella strains as a single dose vaccine against whooping cough | Emerging Cross-Sectional Technologies | 4 | Active |
| US10682377B2 | Mutant Bordetella strains and methods of use | Human Necessities | 4 | Active |
| US11110161B2 | Vaccine for prophylaxis or treatment of an allergen-driven airway pathology | Human Necessities | 3 | Active |
| US8338599B2 | Compounds having a potentiating effect on the activity of ethionamide and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10653765B2 | Vaccine for prophylaxis or treatment of an allergen-driven airway pathology | Human Necessities | 3 | Active |
| US6949345B1 | Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin | Physics | 3 | Expired |
| US11065276B2 | Mutant Bordetella strains and methods of use | Human Necessities | 3 | Active |
| US9730995B2 | Attenuated Bordetella strains | Emerging Cross-Sectional Technologies | 3 | Active |
| US9926346B2 | Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9526778B2 | Influenza vaccine, composition, and methods of use | Emerging Cross-Sectional Technologies | 2 | Active |
| US6472213B1 | Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines | Chemistry; Metallurgy | 2 | Expired |
| US7829103B2 | Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same | Human Necessities | 1 | Active |
| US9180178B2 | Method of using attenuated bordetella strains | Emerging Cross-Sectional Technologies | 1 | Active |
| US10046044B2 | Prevention of pertussis using adenylate cyclase deficient Bordetella strains | Human Necessities | 1 | Active |
| US10369207B2 | Prevention of pertussis using adenylate cyclase deficient Bordetella strains | Human Necessities | 1 | Active |
| US10610580B2 | Attenuated Bordetella strains | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.